Q4 2023 13F Holders as of 31 Dec 2023
-
Type / Class
-
Equity / SPONSORED ADS
-
Total 13F shares
-
83,396,860
-
Share change
-
+2,553,903
-
Total reported value
-
$1,190,086,769
-
Put/Call ratio
-
5.1%
-
Price per share
-
$14.27
-
Number of holders
-
302
-
Value change
-
+$34,664,126
-
Number of buys
-
99
-
Number of sells
-
175
Institutional Holders of TAKEDA PHARMACEUTICAL CO LTD - SPONSORED ADS (TAK) as of Q4 2023
As of 31 Dec 2023,
TAKEDA PHARMACEUTICAL CO LTD - SPONSORED ADS (TAK) was held by
302 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
83,396,860 shares.
The largest 10 holders included
Capital Research Global Investors, Mondrian Investment Partners LTD, MILLENNIUM MANAGEMENT LLC, MORGAN STANLEY, GOLDMAN SACHS GROUP INC, RENAISSANCE TECHNOLOGIES LLC, BRANDES INVESTMENT PARTNERS, LP, MACQUARIE GROUP LTD, FMR LLC, and ARROWSTREET CAPITAL, LIMITED PARTNERSHIP.
This page lists
302
institutional shareholders reporting positions in this security
for the Q4 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.